Thermo Fisher Scientific is cutting 300 employees across two viral vector manufacturing facilities in Massachusetts, marking ...
GH Research has shared compelling data in people with a traditionally challenging form of depression dosed with its ...
For the first time, the FDA will consider whether to approve a trio of drugs for tiny patient populations based on trials ...
Algiax Pharmaceuticals’ non-opioid candidate has achieved “clinically meaningful” pain reduction in a mid-stage trial of ...
Radiopharmaceuticals biotech AdvanCell has pulled together a $112 million Series C about two years after its much smaller ...
Pfizer’s Braftovi combo regimen helped prolong the lives of certain patients with previously untreated colorectal cancer, and ...
Johnson & Johnson’s subcutaneous form of Rybrevant has been recommended for approval by the European Medicines Agency’s human ...
Tectonic plans $185M private placement after stock swings. Acelyrin returns drug to Affibody. Immunome, 89bio complete offerings. Valneva gets $32.8M DoD contract for Ixiaro vaccine.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback